drugset / Trial / NCT00084240
Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective is to confirm the hypothesis that azithromycin (optimal dose once daily for three days) plus chloroquine is non-inferior to sulfadoxine-pyrimethamine plus chloroquine for the treatment of uncomplicated, symptomatic malaria due to P. falciparum.
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- 2005-04
Outcome
Outcome not reported
Stopped: “See Detailed Description”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | — | — |
| Subject | Sulfadoxine-pyrimethamine | Small molecule | — | — |
| Background | Chloroquine | Small molecule | — | — |